|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke:an updated systematic review显示文摘The optimal dose of recombinant tissue plasminogen activator(rtPA)for acute ischaemic stroke(AIS)remains controversial,especially in Asian countries.We aimed to update the evidence regarding the use of low-dose versus standard-dose rtPA.We performed a systematic literature search across MEDLINE,Embase,Cochrane Central Register of Controlled Trials(CENTRAL),PsycINFO and Cumulative Index to Nursing and Allied Health Literature(CINAHL)from inception to 22 August 2016 to identify all related studies.The outcomes were death or disability(defined by modified Rankin Scale 2-6),death,and symptomatic intracerebral haemorrhage(sICH).Where possible,data were pooled for meta-analysis with ORs and corresponding 95% CIs by means of random-effects or fixed-effects meta-analysis.We included 26 observational studies and 1 randomised controlled trial with a total of 23210 patients.Variable doses of rtPA were used for thrombolysis of AIS in Asia.Meta-analysis shows that low-dose rtPA was not associated with increased risk of death or disability(OR 1.13,95% CI 0.95 to 1.33),or death(OR 0.86,95% CI 0.74 to 1.01),or decreased risk of sICH(OR 1.06,95% CI 0.65 to 1.72).The results remained consistent when sensitivity analyses were performed including only low-dose and standard-dose rtPA or only Asian studies.Our review shows small difference between the outcomes or the risk profile in the studies using low-dose and/or standard-dose rtPA for AIS.Low-dose rtPA was not associated with lower risk of death or disability,death alone,or sICH. | Xia Wang Shoujiang You Shoichiro Sato Jie Yang Cheryl Carcel Danni Zheng Sohei Yoshimura Craig S Anderson Else Charlotte Sandset Thompson Robinson John Chalmers Vijay K Sharma | 2018 | Stroke & Vascular Neurology2018，3，1： | 10 |
| 2 | Coagulation activation inyoung survivors of myocardial infarction(MI)-apopulation-basedcase-control study显示文摘 | Brodin E Borvik T Sandset PM | 2004 | Thromb Haemost2004，92，： | 1 |
| 3 | The angiotensin-re- ceptor blocker candesartan for treatment of acute stroke (SCAST) : a randomised, placebo-controlled, double-blind tri- al显示文摘 | Sandset EC Philip MW Boysen G | 2011 | Lancet2011，377，9767： | 1 |
| 4 | Infarction(MI)-a population-based case-cortrol study显示文摘 | BORVIK T SANDSET PM | 2004 | Thromb-Haemost2004，92，： | 1 |
| 5 | Fibrinogen and fibrininduce synthesis of pminilammatory cytokines fwm 1 80-1ated peripheral blood mononuclear cells 显示文摘 | Jensen T Kierulf P Sandset PM | 2007 | Thrmnb Haemost2007，9，7： | 1 |
| 6 | Tissue factor pathway inhibitor (TFPI)-an update显示文摘 | Sandset PM | 1996 | Haemostasis1996，26，： | 1 |
| 7 | A sensitive assay of sic extrinsic coagualation pathway inhibitor(EPI)in plasma fractions显示文摘 | Abildgaard U Pettersen M | 1987 | Thromb Res1987，47，4： | 1 |
| 8 | Venous thromboembolism associated with preg- nancy and hormonal therapy 显示文摘 | Jacobsen AF Sandset PM | 2012 | Best Pract Res Clin Haematol2012，25，3： | 1 |
| 9 | Fibrinogen and fi- brin induce synthesis of proinflammatory cytokines from iso- lated peripheral blood mononuclear cells 显示文摘 | Jensen T Kierulf P Sandset PM | 2007 | Thromb Hae- most2007，97，： | 1 |
| 10 | Coagulation inhibitor levels in pneumonia and stroke:Changes due to consumption and acute phase realtion显示文摘 | Sandset PM Andersson TR | 1989 | J Intern Med1989，225，： | 1 |
| 11 | D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation显示文摘 | Krarup LH Sandset EC Sandset PM | 2011 | Acta Neurologica Scandinavica2011，124，1： | 1 |
| 12 | Coagulat ion inhibition and activation in pancreatic cancer显示文摘 | Odegaard OR Sandset PM | 1992 | Cancer1992，70，： | 1 |
| 13 | The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST):a randomised, placebo-controlled, double-blind trial显示文摘 | Sandset EC Bath PM Boysen G | 2011 | Lancet2011，377，： | 1 |
| 14 | Reduction of factor FⅦa activity during heparin therapy, evidence for assay intemcions with tissue factor pathway inhibitorand antithrombin显示文摘 | Hansen JB Svensson B Sandset PM | 2000 | Thromb Res2000，111，38： | 1 |
| 15 | A unique,low dose of intravenous enoxaparin in elective percutaneous coronary intervention显示文摘 | Hansen JB Sandset PM Huseby KR | 2002 | J Am Coll Cardiol2002，40，： | 1 |
| 16 | Are there Patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin显示文摘 | O’Donnell MJ Berge E Sandset PM | 2006 | Stroke2006，37，2： | 1 |
| 17 | The angiotensin_receptor blocker candesartan for treatment of acute stroke(SCAST):a randomized,placebocontrolled,double_blind trial显示文摘 | Sandset EC Bath PM Boysen QJatuzis D | 2011 | Lancet2011，377，9767： | 1 |
| 18 | Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-a register-based case-control study 显示文摘 | Jacobsen A F Skjeldestad F E Sandset P M | 2008 | Am J Obstet Gynecol2008，198，2： | 1 |
| 19 | Venous thromboembolism associatedwith pregnancy and hormonal therapy 显示文摘 | Anne FJ Per Morten Sandset | 2012 | Best Practice & Re-search Clinical Haematology2012，25，3： | 1 |
| 20 | Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis-the CaVenT Study: Rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)显示文摘 | Tone Enden Leiv Sandvik Nils-Einar Kl?w Geir Hafsahl P?l Andre Holme Lars Olaf Holmen Waleed Ghanima Anne Mette Njaastad Gunnar Sandb?k Carl-Erik Slagsvold Per Morten Sandset | 2007 | American Heart Journal2007，，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员